Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Net Cash Flow (2020 - 2021)

Design Therapeutics' Net Cash Flow history spans 2 years, with the latest figure at -$59.1 million for Q4 2021.

  • For Q4 2021, Net Cash Flow fell 6893.25% year-over-year to -$59.1 million; the TTM value through Dec 2021 reached $296.2 million, up 12766.64%, while the annual FY2025 figure was -$5.7 million, 518.71% down from the prior year.
  • Net Cash Flow for Q4 2021 was -$59.1 million at Design Therapeutics, down from -$13.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $398.3 million in Q1 2021 and bottomed at -$59.1 million in Q4 2021.